PGEN
Price
$1.91
Change
+$0.01 (+0.53%)
Updated
Jul 10 closing price
Capitalization
560.84M
31 days until earnings call
TVRD
Price
$22.67
Change
+$0.54 (+2.44%)
Updated
Jul 10 closing price
Capitalization
207.16M
Interact to see
Advertisement

PGEN vs TVRD

Header iconPGEN vs TVRD Comparison
Open Charts PGEN vs TVRDBanner chart's image
Precigen
Price$1.91
Change+$0.01 (+0.53%)
Volume$1.83M
Capitalization560.84M
Tvardi Therapeutics
Price$22.67
Change+$0.54 (+2.44%)
Volume$19.93K
Capitalization207.16M
PGEN vs TVRD Comparison Chart in %
Loading...
PGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PGEN vs. TVRD commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGEN is a StrongBuy and TVRD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (PGEN: $1.91 vs. TVRD: $22.67)
Brand notoriety: PGEN and TVRD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PGEN: 92% vs. TVRD: 30%
Market capitalization -- PGEN: $560.84M vs. TVRD: $207.16M
PGEN [@Biotechnology] is valued at $560.84M. TVRD’s [@Biotechnology] market capitalization is $207.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PGEN’s FA Score shows that 0 FA rating(s) are green whileTVRD’s FA Score has 1 green FA rating(s).

  • PGEN’s FA Score: 0 green, 5 red.
  • TVRD’s FA Score: 1 green, 4 red.
According to our system of comparison, TVRD is a better buy in the long-term than PGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PGEN’s TA Score shows that 6 TA indicator(s) are bullish while TVRD’s TA Score has 3 bullish TA indicator(s).

  • PGEN’s TA Score: 6 bullish, 4 bearish.
  • TVRD’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, PGEN is a better buy in the short-term than TVRD.

Price Growth

PGEN (@Biotechnology) experienced а +17.90% price change this week, while TVRD (@Biotechnology) price change was +0.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

PGEN is expected to report earnings on Aug 11, 2025.

TVRD is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PGEN($561M) has a higher market cap than TVRD($207M). TVRD YTD gains are higher at: 270.425 vs. PGEN (70.536). PGEN has more cash in the bank: 80.2M vs. TVRD (34.2M).
PGENTVRDPGEN / TVRD
Capitalization561M207M271%
EBITDA-154.85MN/A-
Gain YTD70.536270.42526%
P/E RatioN/AN/A-
Revenue4.2MN/A-
Total Cash80.2M34.2M235%
Total Debt5.42MN/A-
FUNDAMENTALS RATINGS
PGEN vs TVRD: Fundamental Ratings
PGEN
TVRD
OUTLOOK RATING
1..100
2758
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
5
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3734
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
4650

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TVRD's Valuation (5) in the null industry is somewhat better than the same rating for PGEN (70). This means that TVRD’s stock grew somewhat faster than PGEN’s over the last 12 months.

TVRD's Profit vs Risk Rating (100) in the null industry is in the same range as PGEN (100). This means that TVRD’s stock grew similarly to PGEN’s over the last 12 months.

TVRD's SMR Rating (100) in the null industry is in the same range as PGEN (100). This means that TVRD’s stock grew similarly to PGEN’s over the last 12 months.

TVRD's Price Growth Rating (34) in the null industry is in the same range as PGEN (37). This means that TVRD’s stock grew similarly to PGEN’s over the last 12 months.

TVRD's P/E Growth Rating (100) in the null industry is in the same range as PGEN (100). This means that TVRD’s stock grew similarly to PGEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PGENTVRD
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 15 days ago
85%
Bearish Trend 10 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
PGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FVALX5.78N/A
N/A
Forester Value N
JNEMX22.44N/A
N/A
JPMorgan International Equity R6
PHLQX42.39N/A
N/A
PGIM Jennison Health Sciences R6
SMYSX26.79N/A
N/A
Franklin Global Equity IS
CCGEX14.09-0.09
-0.63%
Calamos Global Equity C

PGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PGEN has been loosely correlated with CRSP. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if PGEN jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PGEN
1D Price
Change %
PGEN100%
+0.53%
CRSP - PGEN
48%
Loosely correlated
-1.80%
ARCT - PGEN
48%
Loosely correlated
-2.10%
ALEC - PGEN
46%
Loosely correlated
+4.24%
BEAM - PGEN
46%
Loosely correlated
+2.66%
XENE - PGEN
45%
Loosely correlated
+0.92%
More

TVRD and

Correlation & Price change

A.I.dvisor indicates that over the last year, TVRD has been loosely correlated with APM. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TVRD jumps, then APM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TVRD
1D Price
Change %
TVRD100%
+2.44%
APM - TVRD
41%
Loosely correlated
+3.33%
COEP - TVRD
38%
Loosely correlated
+3.94%
VSTM - TVRD
34%
Loosely correlated
-1.46%
NRXP - TVRD
28%
Poorly correlated
-2.68%
PGEN - TVRD
22%
Poorly correlated
+0.53%
More